Company Filing History:
1 out of 4 
4 out of 832,812 Years Active: 1988-1990
Title: Kevin M. Foley: Pioneering Innovator in Low Molecular Weight Heparin Derivatives
Introduction: Kevin M. Foley, based in Franklin, Ohio, is a notable inventor with a significant contribution to the field of pharmaceutical innovations. With five patents to his name, Foley's work primarily focuses on enhancing the efficacy of low molecular weight heparin.
Latest Patents: Foley's recent patents reflect his commitment to advancing medical science. His notable inventions include:
1. **Low Molecular Weight Heparin Derivatives Having Improved Anti-Xa**: This patent discloses ester derivatives of low molecular weight heparin that exhibit enhanced Anti-Xa activity compared to their global anticoagulation activity. This advancement is crucial for improving treatment efficiency in anticoagulation therapy.
2. **Low Molecular Weight Heparin Derivatives with Improved Permeability**: In this patent, Foley introduces low molecular weight heparin derivatives that contain hydrophobic groups, leading to improved permeability. These derivatives deliver significant anticoagulant activity and enhanced solubility in organic solvents, making them vital for various medical applications.
Career Highlights: Throughout his career, Kevin Foley has made impactful contributions to pharmaceutical research and development. His work has gained recognition in the industry, particularly for his innovative approaches to drug formulation.
Collaborations: In his professional journey, Foley has collaborated with distinguished individuals in the field, including Charles C. Griffin and Eduardo Amaya. These partnerships have fostered a collaborative environment that promotes the exchange of ideas and advancements in pharmaceutical innovation.
Conclusion: Kevin M. Foley stands as a prominent figure in the realm of low molecular weight heparin derivatives. His innovative patents not only contribute to the advancement of medical therapy but also reflect his dedication and expertise in the pharmaceutical industry. Foley’s work continues to inspire future innovations in drug development.